Thyroxine Reveals Addison’s Disease: A Case Report
Cureus · 18.06.2025
DOI: 10.7759/cureus.86299 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 18.06.2025. Verfasst von Vasiliki Rengina Tsinopoulou und 4 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University General Hospital…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Autoimmune polyglandular syndrome type 2 (APS-2) is a rare complex autoimmune endocrinological entity and is reported even more rarely in children and adolescents. It consists of primary adrenal insufficiency (Addison's disease), autoimmune thyroiditis (AIT) and/or type 1 diabetes mellitus (T1DM). Treatment of the AIT component of the disease with levothyroxine as hormone replacement therapy has been reported rarely to cause adrenal crisis. This treatment adverse event is possibly explained due to the increase of basal metabolic rate and subsequently the increased demand and clearance of cortisol after levothyroxine therapy and should always be considered by physicians in order to avoid the development of adrenal crisis. We report the case of a 13-year-old adolescent girl with hypothyroidism due to Hashimoto's thyroiditis (HT) who developed signs of adrenal insufficiency after initial levothyroxine therapy. She was initially admitted with symptoms of hyperthyroidism, including weight loss, anxiety, and oligomenorrhea. A more thorough examination revealed pallor, signs of dehydration, tachycardia, and additionally serum electrolyte imbalance and extremely low cortisol levels in combination with very high adrenocorticotropic hormone (ACTH) levels. The patient received emergency treatment for adrenal insufficiency and recovered well. Due to positive adrenal autoantibodies, APS-2 was confirmed. This case report highlights the necessity of careful adrenal function screening in patients with hypothyroidism and HT before initiating thyroid therapy in order to avoid the rare occurrence of adrenal crisis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2nd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, GRC.
- Program of Postgraduate Studies Adolescent Medicine and Adolescent Health Care, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, GRC.
Zitieren
APA
Tsinopoulou, V. R., Kolanis, S., Katsarou, D., Kotanidou, E. P., & Galli-Tsinopoulou, A. (2025). Thyroxine Reveals Addison’s Disease: A Case Report. Cureus. https://doi.org/10.7759/cureus.86299
Vancouver
Tsinopoulou VR, Kolanis S, Katsarou D, Kotanidou EP, Galli-Tsinopoulou A. Thyroxine Reveals Addison’s Disease: A Case Report. Cureus. 2025. doi:10.7759/cureus.86299
BibTeX
@article{Tsinopoulou2025,
author = {Tsinopoulou, Vasiliki Rengina and Kolanis, Savvas and Katsarou, Dimitra and Kotanidou, Eleni P and Galli-Tsinopoulou, Assimina},
title = {Thyroxine Reveals Addison’s Disease: A Case Report},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.86299}
}
EUVIMED